Quarterly Stock Activity Analysis: Knoll Capital Management LLC
Knoll Capital Management, Llc disclosed purchases this quarter across several sectors including Healthcare and Basic Materials. No sales activity is reported in the available filing.
According to data from Insiderset, Knoll Capital Management LLC's portfolio holdings underwent changes during Q2 2026. The firm's disclosed activities primarily involved adding new positions and increasing existing ones in the Healthcare sector.
The most significant purchase was Elicio Therapeutics Inc (ELTX), which saw a substantial increase of 92.1% in its holdings during this quarter, adding considerable weight to the firm's position.
Additionally, Knoll Capital Management significantly boosted their stake in Abivax SA Spons (ABVX), increasing it by 100% with this quarter marking a full replacement of the previous position.
Furthermore, there were notable increases reported for other Healthcare stocks. The firm increased their holdings in Ocular Therapeutix Inc (OCUL)", which saw its portfolio allocation rise from 2.6% to 6.3%, and Nuvation Bio Inc (NUVB)", where the stake increased by 6.67%. These additions reflect a strategic focus on growth potential within this sector.
In contrast, while there were changes in holdings for several other stocks listed as top positions or tracked in Basic Materials sectors like Agnico Eagle Mines Ltd (AEM), SSR Mining Inc. (SSRM), and Royal Gold Inc. (RGLD) - these changes were reported at 0%, meaning no change from the previous quarter.
The disclosed purchases this quarter by Knoll Capital Management, Llc indicate active investment decisions focused on acquiring or strengthening positions in emerging companies within the Healthcare space.